Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the earnings per share (EPS) high or low?
The earnings per share (EPS) of -0.21 is 57% above its 5-year average of -0.49, near the high end of its 5-year range (-0.67–-0.21).
54.84% above its 12-month average of -0.47.
Reported quarterly EPS; no daily interpolation. Q2 FY2026 (2026-06-30): -0.08.
EPS growth vs the same fiscal quarter in the prior fiscal year, last 40 comparable quarters.
FMP quote price / unrounded diluted EPS from four consecutive issuer fiscal quarters Quote observation: 2026-10-06T13:25:27.300Z. Historical observations retain their original dates. Historical series through 2019-11-15.
EARNINGS PER SHARE (EPS)
-0.21
EARNINGS PER SHARE (EPS) AVG TTM
-0.47
EARNINGS PER SHARE (EPS) AVG 3Y
-0.54
EARNINGS PER SHARE (EPS) AVG 5Y
-0.49
EARNINGS PER SHARE (EPS) AVG 10Y
-0.19
EARNINGS PER SHARE (EPS) AVG 15Y
-0.35
EARNINGS PER SHARE (EPS) AVG 20Y
-0.24
CURRENT VS TTM AVG
+54.84%
CURRENT VS 3Y AVG
+60.75%
CURRENT VS 5Y AVG
+57.00%
CURRENT VS 10Y AVG
-10.00%
CURRENT VS 15Y AVG
+40.55%
CURRENT VS 20Y AVG
+12.10%
Apyx Medical Corporation
Market Cap
$109.49M
Earnings Per Share (EPS)
-0.21
TTM Avg
-0.47
3Y Avg
-0.54
5Y Avg
-0.49
Market Cap
$109.93M
Earnings Per Share (EPS)
-4.80
TTM Avg
-8.13
3Y Avg
-18.81
5Y Avg
-23.77
Market Cap
$108.39M
Earnings Per Share (EPS)
-6.48
TTM Avg
-4.79
3Y Avg
-7.51
5Y Avg
-13.98
Market Cap
$111.17M
Earnings Per Share (EPS)
-0.74
TTM Avg
-0.44
3Y Avg
-1.32
5Y Avg
-1.80
Market Cap
$112.56M
Earnings Per Share (EPS)
-4.09
TTM Avg
-2.59
3Y Avg
-6.03
5Y Avg
-6.97
Market Cap
$106.23M
Earnings Per Share (EPS)
-0.71
TTM Avg
-0.33
3Y Avg
-0.37
5Y Avg
-0.32
Market Cap
$113.77M
Earnings Per Share (EPS)
-1.07
TTM Avg
-1.13
3Y Avg
-1.07
5Y Avg
-0.91
Market Cap
$114.24M
Earnings Per Share (EPS)
-3.21
TTM Avg
-1.79
3Y Avg
-1.14
5Y Avg
-1.14
Market Cap
$104.07M
Earnings Per Share (EPS)
-1.60
TTM Avg
-2.42
3Y Avg
-1.68
5Y Avg
-1.45
| NAME | MARKET CAP | EARNINGS PER SHARE (EPS) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Apyx Medical Corporation (APYX) | $109.49M | -0.21 | -0.47 | -0.54 | -0.49 |
| Immunic, Inc. (IMUX)vs › | $109.93M | -4.80 | -8.13 | -18.81 | -23.77 |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP)vs › | $108.39M | -6.48 | -4.79 | -7.51 | -13.98 |
| Black Diamond Therapeutics, Inc. (BDTX)vs › | $111.17M | -0.74 | -0.44 | -1.32 | -1.80 |
| LENZ Therapeutics, Inc. (LENZ)vs › | $112.56M | -4.09 | -2.59 | -6.03 | -6.97 |
| Cumberland Pharmaceuticals Inc. (CPIX)vs › | $106.23M | -0.71 | -0.33 | -0.37 | -0.32 |
| Coya Therapeutics, Inc. (COYA)vs › | $113.77M | -1.07 | -1.13 | -1.07 | -0.91 |
| Aardvark Therapeutics, Inc. Common Stock (AARD)vs › | $114.24M | -3.21 | -1.79 | -1.14 | -1.14 |
| Definitive Healthcare Corp. (DH)vs › | $104.07M | -1.60 | -2.42 | -1.68 | -1.45 |
| The Joint Corp. (JYNT)vs › | $102.43M | 0.27 | -0.10 | -0.20 | 0.10 |
Trailing EPS (TTM)
$-0.21
Forward EPS (Est.)
$-0.26
P/E Ratio
N/A
Formula: EPS = Net Income / Weighted Average Shares Outstanding
Why EPS matters:
EPS (Earnings Per Share) represents the portion of a company's profit allocated to each outstanding share. Higher EPS indicates greater profitability on a per-share basis.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EARNINGS PER SHARE (EPS) |
|---|---|
| 2025-12-31 | -0.27 |
| 2024-12-31 | -0.66 |
| 2023-12-31 | -0.54 |
| 2022-12-31 | -0.67 |
| 2021-12-31 | -0.44 |
| 2020-12-31 | -0.35 |
| 2019-12-31 | -0.58 |
| 2018-12-31 | 1.93 |
| 2017-12-31 | -0.16 |
| 2016-12-31 | -0.14 |
| 2015-12-31 | -0.22 |
| 2014-12-31 | -0.98 |
| 2013-12-31 | -0.25 |
| 2012-12-31 | 0.04 |
| 2011-12-31 | 0.01 |
| 2010-12-31 | -0.09 |
| 2009-12-31 | 0.04 |
| 2008-12-31 | 0.11 |
| 2007-12-31 | 0.15 |
| 2006-12-31 | 0.19 |
| 2005-12-31 | 0.03 |
| 2004-12-31 | 0.11 |
| 2003-12-31 | 0.05 |
| 2002-12-31 | -0.04 |
| 2001-12-31 | 0.06 |
| 2000-12-31 | 0.04 |
| 1999-12-31 | -0.16 |
| 1998-12-31 | -0.07 |
| 1997-12-31 | 0.01 |
| 1996-12-31 | 0.05 |
